These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 23962558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z, Hong Z, Gao Q, Chen C, Hao Z, Ji T, Hu W, Yan Y, Feng J, Liao S, Wu P, Wang D, Wang S, Zhou J, Ma D.
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [Abstract] [Full Text] [Related]

  • 3. Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
    Park J, Park SY, Kim JH.
    Biochim Biophys Acta; 2016 Feb; 1863(2):236-43. PubMed ID: 26597704
    [Abstract] [Full Text] [Related]

  • 4. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
    Han Z, Feng J, Hong Z, Chen L, Li W, Liao S, Wang X, Ji T, Wang S, Ma D, Chen G, Gao Q.
    Biochem Biophys Res Commun; 2013 May 31; 435(2):188-94. PubMed ID: 23665025
    [Abstract] [Full Text] [Related]

  • 5. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M.
    Cell Physiol Biochem; 2016 May 31; 39(1):242-52. PubMed ID: 27336949
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X, Shen H, Yin X, Long L, Chen X, Feng F, Liu Y, Zhao P, Xu Y, Li M, Xu W, Li Y.
    Oncotarget; 2017 Jun 13; 8(24):39154-39166. PubMed ID: 28388577
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X, Huang L, Zhao Y, Tan W.
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec 13; 45(12):995-1001. PubMed ID: 24145606
    [Abstract] [Full Text] [Related]

  • 9. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, Chen HH, Su WC.
    Am J Respir Cell Mol Biol; 2013 Aug 13; 49(2):241-50. PubMed ID: 23526220
    [Abstract] [Full Text] [Related]

  • 10. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV.
    Clin Cancer Res; 2006 Sep 01; 12(17):5055-63. PubMed ID: 16951221
    [Abstract] [Full Text] [Related]

  • 11. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H, Wei W, Sun Y, Gao J, Wang Q, Zheng J.
    DNA Cell Biol; 2015 Jan 01; 34(1):55-62. PubMed ID: 25211326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 01; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 14. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
    Yu T, Yang Y, Zhang J, He H, Ren X.
    Eur J Pharm Biopharm; 2015 Apr 01; 91():103-10. PubMed ID: 25668779
    [Abstract] [Full Text] [Related]

  • 15. Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling.
    Yan H, Guo BY, Zhang S.
    Biochem Biophys Res Commun; 2016 Feb 19; 470(4):947-54. PubMed ID: 26826383
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 19; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 17. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L, Huang G, Wang R, Pan Y, He Z, Chu X, Song H, Chen L.
    Sci Rep; 2016 Dec 06; 6():38408. PubMed ID: 27922075
    [Abstract] [Full Text] [Related]

  • 18. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN, Suh G, Orozco AF, Sutton MN, Yang H, Wang Y, Mao W, Millward S, Ornelas A, Atkinson N, Liao W, Bast RC, Lu Z.
    Cell Death Dis; 2015 Aug 06; 6(8):e1836. PubMed ID: 26247722
    [Abstract] [Full Text] [Related]

  • 19. MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.
    Yan C, Yang F, Zhou C, Chen X, Han X, Liu X, Ma H, Zheng W.
    Int J Clin Exp Pathol; 2015 Aug 06; 8(3):2710-8. PubMed ID: 26045776
    [Abstract] [Full Text] [Related]

  • 20. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 06; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.